Chemists have succeeded in synthesizing a normal compound that displays promise to be a painkiller--and won't result in the side effects that bedevil analgesics currently utilised to treat acute and Persistent conditions. While the opiate receptor relies on G protein coupling for sign transduction, this receptor was found to https://www.proleviate.com/post/the-new-pain-killer-conolidine